ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 658093 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 658093; 2) Community: the network communities that were significantly associated with the response to NSC 658093; 3) Molecule: the relationships between components within communities and NSC 658093; 4) MDR: the compounds that were significantly associated with the NSC 658093.

NSC Compound Enrichment Correlation
NSC 724631 4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione 0.0115521552688258 -0.019632712
NSC 726768 5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline 0.0115521552688258 0.50706087
NSC 732317 6,7-dichloro-2-methyl-3-(phenylthio)quinoxaline 1,4-dioxide 0.0115521552688258 0.1966343
NSC 756166 GSK312948A 0.0115521552688258 0.21525638
NSC 757306 Pyrimethamine (USAN) 0.0115521552688258 0.17648108
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0115521552688258 0.27420597
NSC 94600 Camptothecin 0.0115521552688258 0.57896787
NSC 340847 4-Selenazolecarboxamide, 2-.beta.-D-ribofuranosyl- 0.0123744972338278 0.16997288
NSC 756134 GSK1023156A 0.0123744972338279 0.12782433
NSC 626030 Naphth[2,3-d]oxazol-4-one, 2-(1,1-dimethylethyl)-9-[(4- fluorophenyl)imino]- 0.012374497233828 -0.32968764
Total:63  Current:16    [First] [Prev] [Next] [Last]